Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
PremiumPress ReleasesCheckpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
1M ago
Checkpoint Therapeutics reports Q2 EPS (18c) vs ($1.05) last year
Premium
The Fly
Checkpoint Therapeutics reports Q2 EPS (18c) vs ($1.05) last year
1M ago
Checkpoint announces FDA acceptance of BLA resubmission for cosibelimab
Premium
The Fly
Checkpoint announces FDA acceptance of BLA resubmission for cosibelimab
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Checkpoint to sell 5.85M shares at $2.05 in registered direct offering
Premium
The Fly
Checkpoint to sell 5.85M shares at $2.05 in registered direct offering
3M ago
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Premium
Press Releases
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
3M ago
Checkpoint Therapeutics: Key Governance and Growth Decisions Approved
PremiumCompany AnnouncementsCheckpoint Therapeutics: Key Governance and Growth Decisions Approved
4M ago
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Premium
Press Releases
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
4M ago
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
Premium
Press Releases
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100